Improved tolerability and quality of life with maintained efficacy using twice-daily low-dose interferon-alpha-2b: results of a randomized phase II trial of low-dose versus intermediate-dose interferon-alpha-2b in patients with metastatic renal cell (Q53223555)
Jump to navigation
Jump to search
scientific article published in November 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Improved tolerability and quality of life with maintained efficacy using twice-daily low-dose interferon-alpha-2b: results of a randomized phase II trial of low-dose versus intermediate-dose interferon-alpha-2b in patients with metastatic renal cell |
scientific article published in November 2006 |
Statements
Improved tolerability and quality of life with maintained efficacy using twice-daily low-dose interferon-alpha-2b: results of a randomized phase II trial of low-dose versus intermediate-dose interferon-alpha-2b in patients with metastatic renal cell (English)
1 reference
Nizar M Tannir
1 reference
Lorenzo Cohen
1 reference
Xuemei Wang
1 reference
Peter Thall
1 reference
Paul F Mathew
1 reference
Eric Jonasch
1 reference
Arlene Siefker-Radtke
1 reference
Lance C Pagliaro
1 reference
Chaan S Ng
1 reference
Christopher Logothetis
1 reference
1 November 2006
1 reference
1 reference
107
1 reference
9
1 reference
2254-2261
1 reference
Identifiers
1 reference